From FHIR-based APIs to “hybrid data models” and blockchain-enabled audit trails, biopharma companies are exploring a range of strategies in their quest to incorporate Real World Data (RWD) into clinical trials. But technology alone won’t resolve the deeper issues at play. From bridging disparate data sources to safeguarding patient privacy under evolving regulations, sponsors face…
How Lantern Pharma and Code Ocean partnered on oncology drug development
A vision for data-driven drug development in oncology When Peter Carr, principal software architect of Lantern Pharma, stepped into his full-time role in September 2020, the company was on the cusp of a transformation. While AI had been a focus for a number of years, a fresh infusion of cash provided a possibility of expanding…